When patients receive a life-saving vaccine, hydrate through an IV or rely on a diagnostic kit for fast results, few think about the polymers that make these devices possible. Yet, behind every syringe, container and inhaler lies a material science story of consistency, compliance and safety. In healthcare, the stakes are high. Materials must perform rigorously in what many call a “zero-fail environment.”
For over two decades, LYB Purell medical-grade polymers have met this challenge across Europe. Now, with the expansion of the Purell portfolio in North America, healthcare manufacturers in the U.S. gain access to a proven portfolio of high-quality materials that are delivered with a service model designed to offer peace of mind. This milestone represents not just a geographic move, but a strategic step forward in advancing healthcare innovation at scale.
Why this expansion matters
The North American healthcare market is one of the world’s fastest growing and most demanding hubs, characterized by tight regulations, rapid innovation cycles and critical supply chain needs. Expanding the Purell portfolio here signals three important shifts:
- A milestone for LYB
Strengthening presence in the healthcare industry reinforces the LYB role as a trusted supplier for medical applications ranging from syringes and IV containers to diagnostic housings and inhalers. - Confidence for customers
The Purell Service Concept sets the portfolio apart. Features like stringent traceability systems, dedicated manufacturing and logistics protocols and a two-year notification of change (NOC) commitment ensure supply predictability and regulatory readiness in ways few suppliers can match. - Enabling healthcare innovation
Materials are not just inputs; they are platforms for innovation. By delivering consistent, compliant and high-performance polymers, the Purell portfolio helps customers pursue the next generation of healthcare solutions.
The healthcare imperative: Reliability above all
Healthcare is unlike any other market segment. This is why LYB emphasizes the Purell portfolio as more than just polymers—it is a promise of reliability.
Natalie Nichols, senior director of Specialties & Performance Products at LYB, shares, “Healthcare is a zero-fail environment. With the Purell portfolio, we are helping customers achieve the performance the industry demands while leveraging our global expertise and local support.”
That reliability is safeguarded through:
- Consistency in formulation and supply chain – ensuring reliability for critical medical applications
- Controlled production environments – safeguarding against contamination risks
- Regulatory readiness – including compliance with USP, EU Pharmacopeia and Drug Master Files (DMFs)
- Change notification commitment – providing manufacturers with two years’ notice before any voluntary material change, a comforting level of predictability
A platform for collaboration
What sets the Purell portfolio of medical-grade polymers apart is not only the portfolio itself but the collaborative framework around it. In today’s healthcare landscape, manufacturers are under pressure to innovate faster, meet evolving regulatory requirements and balance cost with quality.
As Simon Foster, LYB industry marketing manager for Healthcare notes, “Our customers need more than just reliable materials. They need a supplier who understands the unique pressures of the healthcare industry. Expanding Purell medical grade polymers in North America means we can work side by side with them, offering regulatory readiness, technical expertise and the supply confidence they need to innovate with assurance.”
This expansion creates opportunities for closer collaborations in developing new solutions and validating materials for advanced applications.
This expansion is not simply a business decision—it reflects a commitment to aligning people, expertise and technology around the shared aspiration of advancing healthcare.
Looking ahead: A role in the future of healthcare
As healthcare evolves, so do the expectations for materials. Safety and performance remain non-negotiable.
The Purell portfolio positions LYB as a long-term supplier in shaping the future of medical innovation.
From polymer to impact
The expansion of Purell medical grade polymers in North America is not simply about adding a new market to the LYB portfolio. It is about reinforcing the company’s role as a partner in one of society’s most critical industries.
Every syringe filled, every diagnostic kit administered; every IV container delivered represents a patient’s trust. Through the Purell portfolio, LYB is ensuring that trust is well-placed, providing manufacturers with materials they can rely on.
In a world where healthcare is advancing rapidly, our Purell service concept offers not just polymers, but confidence, collaboration and innovation. With this expansion, LYB is helping to shape a future where healthcare systems can continue to deliver the highest standards of care every day, for everyone.
Before using a product sold by a company of the LyondellBasell family of companies (“LyondellBasell”), users should make their own independent determination that the product is suitable for the intended use and can be used safely and legally. LyondellBasell MAKES NO WARRANTY, EXPRESS OR IMPLIED (INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE) OTHER THAN AS AGREED TO BY LyondellBasell IN THE PRODUCT SALE CONTRACT. LyondellBasell prohibits or restricts the use of its products in certain applications. For further information on restrictions or prohibitions of use, please contact a LyondellBasell representative. Users should review the applicable Safety Data Sheet before handling the product. Purell is a trademark owned and/or used by the LyondellBasell family of companies.
Explore solutionSponsored content by LyondellBasell
